Literature DB >> 15831238

Consensus conference on cancer registration of brain and central nervous system tumors.

Bridget J McCarthy1, Carol Kruchko.   

Abstract

The passage of Public Law 107-260, the Benign Brain Tumor Cancer Registries Amendment Act, in October 2002 has made the collection of all primary brain tumors a reality. However, at the first Consensus Conference on Brain Tumor Definition for Registration in 2002, and during the development of training materials for benign brain tumor collection, several issues were identified that were tabled for future discussion. These and other issues were addressed at the subsequent 2003 Consensus Conference on Cancer Registration of Brain and Central Nervous System Tumors, at which the Central Brain Tumor Registry of the United States facilitated a discussion among epidemiologists, neurosurgeons, and neuropathologists. Multidisciplinary consensus was reached on four points, for which the following recommendations were made: (1) amend the histology coding scheme for cysts and tumor-like lesions that currently have a code in the third edition of the International Classification of Disease for Oncology (ICDO), (2) collect data on all instances of specific cysts and tumor-like lesions that are located in brain and other CNS sites but currently lack ICDO codes, (3) establish a new ICDO topography site for skull base tumors for the brain and CNS, and (4) collect data on genetic syndromes in patients diagnosed with brain or CNS tumors. We view this conference as part of a continuing process. Because classification of primary intracranial and other CNS tumors is dynamic, and the registration and coding of these tumors will need to be periodically reviewed.

Entities:  

Mesh:

Year:  2005        PMID: 15831238      PMCID: PMC1871892          DOI: 10.1215/S115285170400050X

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  2 in total

Review 1.  Consensus Conference on Brain Tumor Definition for registration. November 10, 2000.

Authors:  Bridget J McCarthy; Tanya Surawicz; Janet M Bruner; Carol Kruchko; Faith Davis
Journal:  Neuro Oncol       Date:  2002-04       Impact factor: 12.300

Review 2.  The concise handbook of family cancer syndromes. Mayo Familial Cancer Program.

Authors:  N M Lindor; M H Greene
Journal:  J Natl Cancer Inst       Date:  1998-07-15       Impact factor: 13.506

  2 in total
  8 in total

1.  Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.

Authors:  I Baldi; A Gruber; A Alioum; E Berteaud; P Lebailly; A Huchet; T Tourdias; G Kantor; J P Maire; A Vital; H Loiseau
Journal:  Neuro Oncol       Date:  2011-10-06       Impact factor: 12.300

2.  Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004.

Authors:  Luc Bauchet; Hélène Mathieu-Daudé; Pascale Fabbro-Peray; Valérie Rigau; Michel Fabbro; Olivier Chinot; Loreleï Pallusseau; Charlotte Carnin; Karl Lainé; Aline Schlama; Agnes Thiebaut; Maria Cristina Patru; Fabienne Bauchet; Martine Lionnet; Michel Wager; Thierry Faillot; Luc Taillandier; Dominique Figarella-Branger; Laurent Capelle; Hugues Loiseau; Didier Frappaz; Chantal Campello; Christine Kerr; Hugues Duffau; Monique Reme-Saumon; Brigitte Trétarre; Jean-Pierre Daures; Dominique Henin; François Labrousse; Philippe Menei; Jérome Honnorat
Journal:  Neuro Oncol       Date:  2010-04-02       Impact factor: 12.300

3.  Transferrin receptor 2 is frequently and highly expressed in glioblastomas.

Authors:  Alessia Calzolari; Luigi Maria Larocca; Silvia Deaglio; Veronica Finisguerra; Alessandra Boe; Carla Raggi; Lucia Ricci-Vitani; Francesco Pierconti; Fabio Malavasi; Ruggero De Maria; Ugo Testa; Roberto Pallini
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

4.  French brain tumor data bank: methodology and first results on 10,000 cases.

Authors:  Luc Bauchet; Valérie Rigau; Hélène Mathieu-Daudé; Dominique Figarella-Branger; Delphine Hugues; Loreleï Palusseau; Fabienne Bauchet; Michel Fabbro; Chantal Campello; Laurent Capelle; Anne Durand; Brigitte Trétarre; Didier Frappaz; Dominique Henin; Philippe Menei; Jérome Honnorat; François Segnarbieux
Journal:  J Neurooncol       Date:  2007-04-13       Impact factor: 4.130

5.  Incidence of intracranial germ cell tumors by race in the United States, 1992-2010.

Authors:  Jenny N Poynter; Rachel Fonstad; Jakub Tolar; Logan G Spector; Julie A Ross
Journal:  J Neurooncol       Date:  2014-08-03       Impact factor: 4.130

6.  Clinical epidemiology for childhood primary central nervous system tumors.

Authors:  Luc Bauchet; Valérie Rigau; Hélène Mathieu-Daudé; Pascale Fabbro-Peray; Gilles Palenzuela; Dominique Figarella-Branger; Jorge Moritz; Stéphanie Puget; Fabienne Bauchet; Lorelei Pallusseau; Hugues Duffau; Philippe Coubes; Brigitte Trétarre; François Labrousse; Patrick Dhellemmes
Journal:  J Neurooncol       Date:  2008-11-20       Impact factor: 4.130

7.  Astrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment.

Authors:  Amanda M Katz; Nduka M Amankulor; Ken Pitter; Karim Helmy; Massimo Squatrito; Eric C Holland
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

8.  The Evangelismos hospital central nervous system tumor registry: Analysis of 1414 cases (1998-2009).

Authors:  George Stranjalis; Theodosis Kalamatianos; Lampis C Stavrinou; Dimitris Mathios; Christos Koutsarnakis; Chara Tzavara; Maria Loufardaki; Despina Protopappa; Theodore Argyrakos; Dimitra P Rontogianni; Damianos E Sakas
Journal:  Surg Neurol Int       Date:  2013-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.